What happens when the mitochondria inside intestinal cells begin to malfunction? Could changes in cellular energy production affect the intestinal barrier, the gut microbiome, and inflammatory responses?

These questions were central to our latest Mito-Hackers webinar with Dr. José Gilberto Chapa Fernández, a retired military physician and ophthalmologist with more than 30 years of service in the Mexican Armed Forces.

In his Spanish-language presentation, “(−)-Epicatequina y disfunción mitocondrial a nivel intestinal,” Dr. Chapa examined research connecting mitochondrial function with intestinal health and discussed the potential role of (−)-epicatechin in cellular signaling, mitochondrial regulation, and intestinal metabolism.

When Mitochondria Fail, the Intestine Can Suffer

One of the central studies discussed was a 2024 paper published in Cell Host & Microbe by Elisabeth Urbauer, Dirk Haller, and colleagues.

Using genetically modified mice, the investigators disrupted mitochondrial function in intestinal epithelial cells by deleting HSP60, a protein involved in maintaining mitochondrial protein function.

The resulting mitochondrial disturbance caused intestinal tissue injury and changes involving the microbiota. Importantly, the severity and development of injury depended on interactions between intestinal cells, microorganisms, and immune-related regulatory mechanisms.

These findings provide experimental evidence that mitochondrial dysfunction can contribute directly to intestinal injury, rather than merely accompany it.

The Intestinal Barrier: More Than a Physical Wall

The intestinal lining is a selectively permeable barrier. It must absorb nutrients while limiting the passage of potentially harmful substances.

Dr. Chapa discussed how mitochondrial dysfunction, epithelial damage, and disruption of proteins involved in cell-to-cell junctions may influence this protective barrier.

When intestinal barrier function deteriorates, microbial products may have greater opportunities to interact with immune tissues, contributing to inflammatory responses.

This creates an important research question: Could maintaining mitochondrial function help preserve the cellular processes that support intestinal barrier integrity?

Dr. Chapa connected this question to his interest in (−)-epicatechin and its possible effects on mitochondrial signaling.

What Happens to Epicatechin in the Intestine?

Another major theme was that ingested (−)-epicatechin does not remain unchanged as it moves through the digestive system.

Following oral consumption, some epicatechin is absorbed and metabolized in the small intestine. Additional transformations occur through interactions with microorganisms in the colon.

These microbial processes generate compounds known as phenyl-γ-valerolactones, among other metabolites.

A review of epicatechin absorption and metabolism describes how these metabolites enter circulation and contribute to the body's overall exposure to epicatechin-derived compounds.

Research has also found that different individuals' gut microbial communities can process epicatechin at different rates, producing different metabolite profiles.

This raises an interesting possibility: the biological responses associated with epicatechin may depend partly on the microorganisms responsible for transforming it.

Beyond Antioxidants: Mitochondrial Signaling

During the webinar, Dr. Chapa discussed several signaling regulators associated with mitochondrial metabolism, including SIRT1, AMPK, and PGC-1α.

PGC-1α is involved in regulating mitochondrial biogenesis, the process through which cells increase their mitochondrial content.

His presentation examined how (−)-epicatechin is being investigated in relation to these pathways and how physical exercise may interact with mitochondrial regulatory processes.

These mechanistic questions are scientifically interesting, but identifying activity in a cellular pathway is not the same as demonstrating that a compound can treat intestinal disease in humans.

Further clinical research is needed to determine whether the experimental findings translate into measurable benefits for intestinal health.

From Experimental Findings to Clinical Questions

The discussion concluded with questions about how mitochondrial research might eventually inform clinical practice.

During the Q&A, Dr. Chapa addressed the challenges of translating experimental results into medical interventions, ways of evaluating mitochondrial function, the relationship between physical exercise and mitochondrial health, and his personal interest in mitochondrial biology.

The underlying question remains compelling: How much of intestinal health depends on the condition of the mitochondria within its cells, and can that relationship become a useful target for future interventions?

Research is beginning to provide answers at the cellular and experimental levels. Establishing effective clinical applications will require further human studies.

Watch the Full Mito-Hackers Presentation

The complete Spanish-language presentation by Dr. José Gilberto Chapa Fernández, along with the separate questions-and-answers recording, is available to Mito-Hackers community members.

The recordings cover the studies, biological pathways, epicatechin metabolism, and clinical questions discussed during the session in greater detail.

Watch the full presentation and Q&A in Mito-Hackers

Recorded October 15, 2026. Presented in Spanish.

Selected research

1. Urbauer E, et al. (2024). Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease. Cell Host & Microbe.

2. Borges G, et al. (2018). Absorption, metabolism, distribution and excretion of (−)-epicatechin: A review of recent findings. Molecular Aspects of Medicine.

3. Liu C, et al. (2020). Interindividual Differences in Human Intestinal Microbial Conversion of (−)-Epicatechin to Bioactive Phenolic Compounds. Journal of Agricultural and Food Chemistry.

Long before researchers began isolating flavanols or studying mitochondrial signaling, cacao already held an important place in Mesoamerican cultures. It was consumed as a beverage and used in social, ceremonial, and cultural settings for centuries before chocolate became part of European and, later, global food culture.

That history provided an interesting starting point for Dr. Francisco Villarreal’s October 8 Mito-Hackers presentation.

But the central scientific question came much later:

What compounds in cocoa might be responsible for some of the biological effects observed in modern research?

That question eventually brought (-)-epicatechin into focus.

In this Mito-Hackers webinar, Dr. Francisco Villarreal, co-founder and Chief Medical Officer of FMG Health Sciences, traced the path from the historical importance of cacao to modern experimental work on cocoa flavanols, epicatechin, cellular signaling, and mitochondrial biology.

Cacao Before the Laboratory

Cacao has a deep history in Mesoamerica, where it was consumed long before the development of modern chocolate.

Dr. Villarreal touched on this history as part of the broader story of how human interest in cacao evolved over time.

That historical context is important, but it is distinct from modern biomedical research.

Traditional use can tell us that a plant or food has been culturally important for a long time. It does not by itself establish how a particular molecule works in the body.

That requires controlled scientific investigation.

And that is where the modern epicatechin story begins.

From Cocoa to a Specific Molecule

Cocoa contains many biologically active compounds.

So when researchers began observing physiological effects associated with cocoa consumption, an obvious question followed:

Which components were responsible?

Dr. Villarreal and Dr. Guillermo Ceballos were among the researchers who began looking more closely at that problem.

Over time, (-)-epicatechin, one of the flavanols naturally present in cocoa, became a molecule of particular interest.

The scientific question then changed.

Instead of asking only what cocoa as a whole might do, researchers could begin studying isolated (-)-epicatechin under controlled experimental conditions.

That shift allowed the research to become much more precise.

Following the Biology

Once epicatechin became an experimental molecule rather than simply one component of cocoa, the research began expanding into several areas of physiology.

These included:

• cardiovascular biology,

• skeletal muscle,

• cellular signaling,

• metabolic regulation,

• and mitochondrial biology.

This is an important part of the story because biological molecules rarely operate through one isolated mechanism.

Cellular signaling can influence metabolism. Metabolism affects mitochondrial behavior. Mitochondria, in turn, participate in energy production, cellular signaling, stress responses, adaptation, and programmed cell death.

As the research progressed, the questions surrounding epicatechin became broader than the original cocoa hypothesis.

When Mitochondria Became Part of the Story

Mitochondria emerged as an important area of investigation as researchers studied changes related to cellular energy systems, mitochondrial structure, and signaling.

This moved the discussion well beyond the familiar description of mitochondria as simply the cell’s “powerhouses.”

Mitochondria are dynamic structures.

Their number, organization, activity, and turnover can change in response to exercise, disease, aging, nutrient availability, and cellular stress.

Understanding whether a molecule influences mitochondrial biology therefore requires much more than measuring energy production alone.

Researchers must ask which pathways are changing, under what conditions, in which tissues, and whether findings from experimental models are also relevant in humans.

How a Scientific Question Becomes a Research Program

One of the most interesting parts of Dr. Villarreal’s presentation was the way the research evolved.

Scientific programs rarely follow a straight path.

An observation leads to a hypothesis.

A hypothesis leads to an experiment.

The result of that experiment often creates several new questions.

Some findings support the original idea. Others force researchers to revise it.

Over time, work that began with cocoa and dark chocolate expanded into a much broader investigation of (-)-epicatechin across different biological systems.

That progression is a good example of how science actually develops.

It is not a single experiment producing a final answer. It is the accumulation of evidence over years.

From Research to Mitozz

The research program began long before Mitozz existed.

Years of work examining (-)-epicatechin eventually became part of the scientific foundation behind Mitozz, which contains high-purity (-)-epicatechin.

The order matters.

The research did not begin with a product and then search for evidence to support it.

It began with biological questions about cocoa, moved toward the study of a specific molecule, and expanded as new experimental findings emerged.

That history helps explain why the scientific story behind Mitozz extends much further back than the product itself.

From Mesoamerica to Modern Mitochondrial Biology

Taken as a whole, Dr. Villarreal’s presentation covered an unusually long scientific and historical arc.

It began with cacao’s place in Mesoamerican culture.

It moved through the modern study of cocoa and dark chocolate.

Then came the identification and investigation of (-)-epicatechin.

And eventually, the research reached questions involving cellular signaling, muscle biology, cardiovascular physiology, and mitochondria.

The connection between those stages is not that ancient cacao use predicted modern molecular biology.

It is that a food with a very long human history eventually became the subject of increasingly precise scientific questions.

Those questions led researchers from the whole food, to individual compounds, to molecular pathways, and finally to some of the fundamental processes that regulate how cells function.

Watch the Full Mito-Hackers Presentation

Dr. Francisco Villarreal
From Dark Chocolate Biology to Epicatechin: How a Scientific Hypothesis Became a Research Program

The full presentation and Q&A are available to Mito-Hackers members.

In the presentation, Dr. Villarreal discusses the history of cacao, the origins of the cocoa and epicatechin research program, how the scientific questions changed over time, and how that work eventually expanded into broader areas of cellular and mitochondrial biology.

Presentation date: October 8, 2026
Language: English

For many women, the years surrounding menopause are associated with familiar symptoms such as hot flashes, changes in sleep, mood and body composition.

But another change may be occurring less visibly: cardiovascular risk can also shift during this stage of life.

In a recent Mito-Hackers webinar, Dr. Nayelli Nájera García examined the relationship between the menopausal transition, metabolic health and cardiovascular function, and presented research investigating (-)-epicatechin in postmenopausal women with metabolic syndrome.

The discussion highlighted an important point: cardiovascular health during and after menopause cannot be understood simply by looking at estrogen levels alone.

Perimenopause is a transition, not a single event

Menopause refers to the permanent cessation of menstruation, but the biological transition begins years earlier.

During perimenopause, hormones such as estradiol and progesterone can fluctuate considerably before eventually declining. Nayelli explained that this transition can last for several years and that women may experience a wide range of physical and psychological symptoms during that time.

However, not every symptom commonly attributed to menopause appears to be caused directly by hormone concentrations.

Vasomotor symptoms, including hot flashes and sweating, have a clearer relationship with hormonal changes. Other experiences may also be influenced by aging, body composition, metabolic health, social circumstances and other factors present when a woman enters this stage of life.

This makes the condition of the body before and during the transition particularly important.

Body fat distribution also changes

One change discussed during the presentation was the tendency for fat distribution to shift during this period.

Rather than being concentrated predominantly around the hips, more fat may accumulate in the abdominal and visceral regions.

That distinction matters because visceral adipose tissue is metabolically active. It can participate in inflammatory and metabolic signaling and is associated with many of the abnormalities seen in overweight, obesity and metabolic syndrome.

At the same time, loss of muscle mass can also occur with aging.

The result is that hormonal change, body composition, aging and metabolic health may all be occurring together rather than as isolated processes.

Cardiovascular disease in women can be easier to overlook

One of the questions raised after the presentation was why cardiovascular disease has historically been more difficult to identify in women.

Nayelli pointed to several factors.

For many years, much biomedical and cardiovascular research was conducted predominantly in males. Even preclinical studies frequently used male animals, meaning that much of the historical evidence base was built around male physiology.

Women also do not necessarily experience cardiovascular disease in exactly the same way as men.

During the discussion, Nayelli noted that symptoms associated with myocardial infarction can differ between women and men, which can make recognition more difficult when expectations are based primarily on the classic male presentation.

The larger point is not simply that women's cardiovascular risk changes with menopause, but that female cardiovascular physiology deserves to be studied on its own terms.

A standard cholesterol number does not tell the entire story

A central part of Nayelli's presentation focused on lipoproteins.

Cholesterol and triglycerides do not circulate freely in the blood. They are transported within lipoprotein particles, and those particles can differ considerably in size and density.

Two people can therefore have similar concentrations of LDL cholesterol while having different distributions of LDL particles.

Nayelli described smaller, denser LDL particles as having more atherogenic characteristics because they can more readily enter a dysfunctional vascular endothelium. Once retained and oxidized, these particles can participate in inflammatory processes involved in the development of atherosclerotic plaque.

Larger, more buoyant particles behave differently.

This means that looking only at the total concentration of cholesterol contained within the particles may not reveal everything about their distribution.

In the women studied by Nayelli's research group, total LDL measures could appear relatively unremarkable while analysis of the lipoprotein subclasses revealed increased numbers of small and very small particles.

What the epicatechin study examined

An important distinction is that although the webinar discussed perimenopause broadly, the intervention study Nayelli presented involved postmenopausal women.

The study recruited women between approximately 50 and 60 years of age who had metabolic syndrome.

Participants had at least three metabolic risk factors such as increased waist circumference, elevated triglycerides, low HDL cholesterol, elevated glucose or elevated blood pressure.

Of the women screened, 40 met the inclusion criteria and were randomly assigned to either a placebo group or an (-)-epicatechin intervention group in a double-blind, placebo-controlled design.

The intervention lasted three months.

Researchers examined not only conventional metabolic measurements but also the number and size distribution of lipoprotein particles.

The lipoprotein pattern shifted after epicatechin

According to the results Nayelli presented, the placebo group showed an increase in small and very small lipoprotein particles during the three-month period.

In the epicatechin group, the pattern moved in the opposite direction.

The number of smaller, more atherogenic particles decreased, while larger and more buoyant particles increased.

When the researchers plotted the overall distribution, the lipoprotein profile shifted away from the smaller particle sizes and toward medium and larger particles following the intervention.

The study also examined markers associated with vascular health.

Nayelli reported reductions in TNF-alpha, a marker associated with inflammation, as well as changes in other markers related to endothelial function. Polysulfide concentrations also increased in the intervention group, which the researchers interpreted in the context of endothelial function and vasodilation.

These findings came from a relatively small group of postmenopausal women with metabolic syndrome, so they should be understood in the context of that specific study population rather than assumed to apply to every woman going through menopause.

Where mitochondria enter the picture

Nayelli connected these findings with mitochondrial metabolism.

Mitochondria participate in beta-oxidation, one of the major pathways through which fatty acids are metabolized.

The liver is central to lipid metabolism, and when energy intake and lipid accumulation exceed the body's ability to process them efficiently, metabolic abnormalities can develop alongside mitochondrial dysfunction.

The research program presented during the webinar is examining whether supporting mitochondrial function with (-)-epicatechin can influence the way lipids are handled and, in turn, affect downstream metabolic and vascular markers.

That offers a different way of looking at cardiovascular health.

Rather than treating cholesterol, inflammation, endothelial function and mitochondrial metabolism as completely separate processes, the presentation showed how they may interact.

Menopause may be a useful window for paying closer attention

Perhaps the broader message from the webinar was that menopause should not be viewed only as the end of reproductive function.

It occurs during a period when body composition, metabolism and cardiovascular risk may all be changing.

Nayelli also emphasized during the Q&A that women do not arrive at this transition in identical physiological condition. Exercise, nutrition, weight, metabolic health and other factors accumulated over many years can influence how the transition is experienced.

That makes the years around menopause an important opportunity to pay closer attention to cardiovascular and metabolic health.

The epicatechin study presented during the webinar offers an interesting piece of that larger picture, particularly because it looked beyond standard cholesterol measurements to examine changes in lipoprotein particles and endothelial markers.

It also leaves important questions open.

Future research could examine women earlier in the menopausal transition and study outcomes such as cognitive function, quality of life and symptoms associated specifically with perimenopause.

For now, the work presented by Nayelli reinforces a broader idea: understanding cardiovascular health in women requires looking beyond reproductive hormones alone and considering metabolism, vascular function, body composition and mitochondrial biology together.

Watch the full presentation

Mito-Hackers members can watch Dr. Nayelli Nájera García’s full presentation and Q&A, presented in Spanish, in the Webinars & Events section of the community.

What if mitochondrial health were considered earlier in clinical care, before a patient developed obvious loss of function?

That was the central idea behind a recent Mito-Hackers webinar presented by Dr. José Gilberto Chapa Fernández, a physician, ophthalmologist, retired military doctor, and graduate of Mexico’s Escuela Médico Militar with more than 30 years of service in the Armed Forces.

Rather than approaching mitochondrial function as a topic limited to one disease or one medical specialty, Dr. Chapa proposed a broader clinical model: consider cellular energy production, mitochondrial function, physical capacity, and metabolic health as connected parts of patient care.

His presentation, “Intervención Mitocondrial Regenerativa: Modelo de Atención Clínica,” asked how mitochondrial biology might be incorporated into prevention, prehabilitation, healthy aging, and clinical follow-up.

Moving mitochondrial health earlier in the clinical conversation

Modern medicine often becomes most active after symptoms appear.

Dr. Chapa proposed thinking about mitochondrial health earlier.

The goal is not to diagnose every symptom as a mitochondrial problem. Rather, his model asks clinicians to consider whether cellular energy production and metabolic capacity may influence how well a person tolerates physiological demands.

This becomes especially interesting in situations such as aging, physical deconditioning, recovery from illness or surgery, and declining exercise capacity.

In the webinar introduction, this was described as a form of primordial prevention: thinking about biological function before a defined disease process becomes established.

That distinction is important.

The objective is not simply to treat disease earlier. It is to preserve enough physiological capacity that the body is better prepared when it encounters physical stress.

Why mitochondria provide a common biological starting point

Different organs perform very different jobs.

The retina processes light. Skeletal muscle generates movement. The heart contracts continuously. The brain coordinates enormous amounts of information.

Yet these tissues share one basic requirement:

They need energy.

Mitochondria convert nutrients into ATP, the chemical energy cells use to perform much of their work.

Dr. Chapa used his own specialty, ophthalmology, to illustrate this concept. The visual system has a high metabolic demand, and retinal cells rely heavily on mitochondrial energy production to maintain their normal function.

The same general principle applies throughout the body.

Cells with high energy requirements tend to contain large numbers of mitochondria, which is one reason mitochondrial biology is relevant across specialties rather than belonging to one particular organ system.

Mitochondria are not static structures

Another important part of the presentation was the idea that mitochondria continually change.

Cells can produce new mitochondria through mitochondrial biogenesis. They can also identify and remove damaged mitochondria through processes including mitophagy.

These mechanisms form part of mitochondrial quality control.

Physical activity provides one of the best-known biological signals supporting mitochondrial adaptation. When muscle is repeatedly asked to perform work, cells respond by adjusting their metabolic machinery to meet that demand.

This is one reason regular exercise has effects that extend well beyond simply burning calories.

Exercise asks the body to become better prepared for the next physical challenge.

Aging changes the equation

Mitochondrial function does not remain identical throughout life.

With aging, mitochondrial quality control, energy metabolism, muscle function, and physical capacity can all change.

These changes do not occur at exactly the same rate in everyone, but they help explain why older adults can gradually become less able to tolerate demands that once seemed routine.

Walking a long distance may become harder.

Recovery after physical exertion may take longer.

Muscle strength can decline.

Illness or a period of bed rest may produce a larger loss of function than it would have earlier in life.

For Dr. Chapa, this is one reason mitochondrial health should not be considered only after severe functional decline has already occurred.

From prevention to prehabilitation

One of the most useful applications of this idea is prehabilitation.

Rehabilitation takes place after an injury, illness, or procedure.

Prehabilitation asks a different question:

Can we improve a person's functional reserve before the challenge occurs?

Before major surgery, for example, clinicians may consider exercise capacity, nutrition, muscle strength, cardiovascular health, metabolic status, and other factors that could influence recovery.

Mitochondrial function fits naturally into that discussion because many recovery processes require energy.

Tissue repair requires energy.

Immune responses require energy.

Movement requires energy.

Restoring physical function requires energy.

Thinking about cellular energy does not replace conventional medical assessment. It provides another biological layer through which clinicians can think about a patient's capacity to respond.

A clinical model should focus on function, not just mitochondria

One challenge is that measuring mitochondrial number or function directly is not practical in an ordinary medical consultation.

During the webinar Q&A, Dr. Guillermo Ceballos discussed this distinction.

Mitochondrial density can be examined with specialized laboratory methods, including analysis of tissue samples, but that is usually inappropriate for routine clinical monitoring.

Instead, clinicians can follow functional and metabolic outcomes.

Depending on the patient, those might include:

• Grip strength

• Walking capacity

• Exercise tolerance

• Changes in muscle function

• Appropriate metabolic markers

• Ability to perform normal daily activities

• Recovery after physical exertion

This is a useful distinction because a clinical mitochondrial model should ultimately be concerned with the patient's function, not simply with producing a laboratory number.

Where does (-)-epicatechin fit?

A major part of Dr. Chapa's presentation focused on (-)-epicatechin, a naturally occurring flavanol that has been studied by researchers including Dr. Guillermo Ceballos, Dr. Francisco Villarreal, and their collaborators.

Dr. Chapa proposed incorporating epicatechin into his mitochondrial intervention model alongside physical activity and other aspects of clinical care.

Research discussed across previous Mito-Hackers presentations has examined epicatechin in relation to mitochondrial biogenesis, mitochondrial structure and function, muscle physiology, vascular biology, and metabolic signaling.

During the Q&A, Dr. Ceballos described work examining signaling pathways associated with mitochondrial biogenesis, including pathways involving PGC-1α and downstream regulators of mitochondrial formation.

That research provides a biological basis for studying epicatechin in mitochondrial and metabolic contexts.

It is important, however, to distinguish research on biological mechanisms from claims that a compound can independently treat a particular disease.

Dr. Ceballos made this distinction explicitly during the discussion: epicatechin should not be presented as a replacement for appropriate medical treatment.

A mitochondrial approach is not a replacement for disease-specific medicine

This is particularly important when applying a broad biological concept to clinical care.

Mitochondria are involved in many cellular processes, but that does not mean every disease can be reduced to mitochondrial dysfunction.

A patient with cardiovascular disease still requires cardiovascular evaluation.

A person with diabetes still requires appropriate metabolic management.

A patient with cancer requires oncology care.

An ophthalmic condition requires appropriate ophthalmological assessment and treatment.

The value of a mitochondrial framework is not that it replaces those specialties.

It is that it asks an additional question:

What is happening to the patient's underlying physiological capacity while the disease itself is being treated?

That is a much more defensible and clinically useful way to think about mitochondrial intervention.

Exercise remains one of the clearest mitochondrial interventions

Throughout the webinar, exercise repeatedly appeared as an important reference point.

Physical activity places controlled demands on muscle and energy metabolism. In response, the body adapts.

That includes adaptations involving mitochondrial biogenesis, metabolic efficiency, cardiovascular function, and skeletal muscle.

This is why a mitochondrial care model should not be reduced to supplementation.

Movement matters.

Nutrition matters.

Sleep matters.

Metabolic health matters.

Avoiding prolonged inactivity matters.

And when illness, surgery, age, or disability limits those behaviors, the clinical question becomes how much functional capacity can reasonably be preserved or restored.

The larger idea: medicine as coordination

Dr. Chapa described his broader approach using the analogy of an orchestra.

Different areas of medicine are like different instruments. Each has a particular role, but the patient ultimately experiences them as one biological system.

A mitochondrial perspective fits this analogy well.

Cardiovascular function affects oxygen and nutrient delivery.

Muscle determines physical capacity.

The nervous system coordinates movement.

Nutrition supplies metabolic substrates.

Mitochondria help transform those substrates into usable cellular energy.

None functions independently.

The purpose of an integrative clinical model, therefore, should not be to replace one specialty with another. It should be to understand where those systems intersect.

From treating disease to preserving capacity

Perhaps the most useful question raised by the webinar was not about any single supplement or pathway.

It was about when clinical care should begin thinking about loss of function.

Should we wait until an older adult can no longer climb stairs?

Until prolonged inactivity has produced substantial muscle loss?

Until recovery from a procedure becomes difficult?

Or can clinicians begin thinking earlier about strength, activity, metabolic health, nutrition, and physiological reserve?

Mitochondrial biology offers one framework for asking those questions.

The objective is not to promise that aging or disease can be eliminated.

It is to preserve as much function, independence, and capacity as possible for as long as possible.

Continue the Discussion in Mito-Hackers

This Briefing is based on the Mito-Hackers webinar “Intervención Mitocondrial Regenerativa: Modelo de Atención Clínica,” presented by Dr. José Gilberto Chapa Fernández.

Mito-Hackers members can watch the complete Spanish-language presentation and Q&A, where Dr. Chapa discusses his proposed clinical model, mitochondrial energy metabolism, prevention and prehabilitation, physical activity, and research involving (-)-epicatechin in greater detail.

Already a member? Sign in to Mito-Hackers to watch the complete webinar.

Interested in joining? Apply for access to participate in future webinars, scientific discussions, and member-only content.

This Briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

In a recent Mito-Hackers webinar, Dr. Francisco Villarreal, Co-Founder and Chief Medical Officer of FMG Health Sciences and a physician-scientist at the University of California, San Diego, examined the relationship between mitochondrial health, aging, frailty, and sarcopenia.

His presentation focused on an important idea: age-related loss of physical capacity is not simply a matter of losing muscle.

Muscle function depends on energy production, metabolism, neurological control, physical activity, and the health of the cells themselves. Mitochondria sit at the center of several of these processes because they provide the ATP that muscle and other tissues require to function.

Understanding what happens to mitochondria as we age may therefore help explain some of the biological changes that accompany declining strength and mobility.

Frailty and sarcopenia are related, but they are not the same thing

Dr. Villarreal began by distinguishing two terms that are often discussed together.

Frailty is a broader state in which the body's physiological reserves have declined to the point that it becomes less able to cope with physical stressors.

Sarcopenia refers more specifically to loss of skeletal muscle mass and function and is an important component of frailty.

That distinction matters because someone can experience more than a simple reduction in muscle size.

Age-related changes can affect:

• Muscle strength

• Muscle quality

• Walking speed

• Balance and coordination

• Physical activity

• Metabolic function

• The ability to recover from physical challenges

Dr. Villarreal also described several commonly used indicators of frailty, including unintended weight loss, self-reported exhaustion, weakness, slower walking speed, and reduced physical activity.

Together, these measures help describe something broader than muscle loss alone: a decline in the body's ability to maintain physical function.

Why mobility matters as we age

One of the recurring themes in the presentation was the importance of mobility.

When strength begins to decline, normal activities can gradually become more difficult. A person may walk less, avoid stairs, spend less time outside, or stop doing activities that once formed part of everyday life.

That reduction in activity can itself create additional problems.

Muscles receive less mechanical stimulation. Bones experience less loading. Physical conditioning declines. Over time, it may become even harder to resume previous levels of activity.

Dr. Villarreal discussed frailty as an important clinical issue because it is associated with outcomes including falls, loss of independence, hospital admission, and the need for greater levels of care. He also noted that frailty becomes increasingly common at advanced ages.

This makes preserving mobility about much more than athletic performance.

The ability to walk, stand, carry objects, climb stairs, shop, garden, or move independently can have a major effect on quality of life as people grow older.

Where do mitochondria fit into aging and muscle function?

Skeletal muscle requires large amounts of energy.

Mitochondria help provide that energy by converting components of the food we eat into ATP, the form of chemical energy cells use to perform work.

ATP supports muscle contraction, but mitochondrial energy production is also needed throughout the body. Dr. Villarreal pointed out that mitochondrial energy supports functions in the heart, brain, eyes, skeletal muscle, and other organs.

This becomes particularly relevant when considering aging.

According to Dr. Villarreal, mitochondria in older tissues may not function as efficiently as healthier mitochondria. Energy production can decline while production of reactive oxygen species can increase.

Reactive oxygen species are not inherently harmful. They participate in normal cellular signaling.

The problem arises when their production exceeds the body's ability to regulate them.

Excess reactive oxygen species can contribute to oxidative stress, which in turn can participate in inflammatory processes and cellular damage.

Dr. Villarreal summarized the aging pattern as a combination of reduced mitochondrial energy output together with increased oxidative stress and inflammation.

Muscle aging is more than a loss of muscle mass

This helps explain why sarcopenia cannot be understood simply by looking at the amount of muscle a person has.

Muscle tissue must also be able to produce energy efficiently.

Dr. Villarreal described mitochondrial damage and depletion as being associated with the progression of muscle weakness. Skeletal muscle depends on adequate ATP production, and changes that impair mitochondrial function may therefore contribute to declining muscle performance.

He also discussed several biological stresses that can affect mitochondrial health, including oxidative stress, altered calcium handling, poor blood flow, and metabolic disease.

The central point is that muscle function depends on both the muscle tissue itself and the cellular machinery that allows that tissue to work.

As a result, two people with similar amounts of muscle may not necessarily have the same physical capacity.

Aging also affects the body's ability to maintain healthy mitochondria

Cells have mechanisms that help maintain mitochondrial health.

But Dr. Villarreal explained that these mechanisms can become less effective with age.

This creates another challenge.

At the same time that older adults may need to preserve mitochondrial function, they may also find it increasingly difficult to maintain the levels of physical activity that help support muscle and metabolic health.

Exercise was an important part of this discussion.

Dr. Villarreal described physical activity as one of the established ways to support mitochondrial and muscle function. Healthy nutrition was also identified as part of maintaining physical capacity.

The challenge is that once mobility begins to decline, maintaining adequate exercise may become progressively harder.

This can create a cycle:

less strength → less movement → less physical stimulation → further decline in strength and capacity

Breaking or slowing that cycle becomes increasingly important with age.

Exercise, muscle, and bone are closely connected

The Q&A expanded this idea beyond muscle.

Dr. Villarreal discussed how declining activity can affect bone health as well.

When an older adult becomes less active because of frailty or sarcopenia, the bones receive less mechanical loading. Bone tissue responds to physical stress, so reduced movement may contribute to loss of bone strength over time.

Conversely, maintaining or restoring physical activity provides mechanical stimulation to both muscle and bone.

This is another reason mobility matters so much.

Walking, resistance exercise, and ordinary weight-bearing activity provide signals that help maintain the tissues required for continued movement.

Muscle, bone, and mitochondrial function are therefore not isolated systems.

They interact continuously.

What has research on (-)-epicatechin examined?

The latter part of the presentation focused on (-)-epicatechin, a naturally occurring flavanol that Dr. Villarreal and his collaborators have studied extensively.

He described research examining epicatechin in relation to mitochondrial function, structure, and density.

Dr. Villarreal then presented results from a human proof-of-concept study conducted in an older population in Mexico City.

The study included 74 men and women between 65 and 90 years old who had sarcopenia, including low muscle mass together with reduced grip strength and walking performance.

Participants were enrolled in a randomized, double-blind controlled study and received either a control beverage or an epicatechin-rich beverage for three months.

Researchers evaluated both biochemical and physical measures.

These included:

• Six-minute walking distance

• Step performance

• Sit-to-stand performance

• Timed mobility

• Grip strength

• Markers of oxidative stress

• Markers of inflammation

• Measures related to metabolic health

• Quality of life

Dr. Villarreal reported differences between the groups in several of these measures.

Participants receiving the flavanol-rich beverage showed improvements in walking performance, step measures, sit-to-stand performance, and grip strength compared with the control group. He also presented reductions in markers of oxidative stress and discussed changes in inflammatory and metabolic measures.

Because Dr. Villarreal presented this work as a proof-of-concept study, the results are best understood in the context of the specific population and study design rather than as a general conclusion about all older adults.

The study does, however, provide an example of how researchers are beginning to investigate the relationship between mitochondrial biology and measurable physical function in humans.

Mitochondrial health affects more than muscle

During the Q&A, Dr. Villarreal was also asked whether mitochondrial dysfunction in frailty extends beyond skeletal muscle.

His answer was yes.

Mitochondria are present throughout the body, including in cells of the heart, brain, kidneys, eyes, and other organs.

These tissues all depend on mitochondrial energy production to maintain normal function.

This means that mitochondrial aging should not be thought of solely as a muscle issue.

Frailty is a whole-body condition, and mitochondrial changes may occur across several organ systems at the same time.

That broader view helps explain why frailty can involve fatigue, reduced mobility, weakness, slower recovery, and declining physiological reserve rather than one isolated symptom.

How can someone notice declining physical capacity?

One of the most practical questions in the discussion was how an older person might begin to assess changes in their own physical capacity.

Dr. Villarreal suggested using your own previous level of function as a reference point.

Questions might include:

How many flights of stairs can you climb before becoming tired?

Can you still walk the same distances you could several years ago?

Have ordinary physical activities become noticeably more difficult?

Do you feel more exhausted during the day?

Has your strength declined?

Are you moving less than you used to?

How rested do you feel when you wake up?

This approach is useful because aging does not occur at exactly the same rate in everyone.

Comparing yourself with another person of the same age may tell you very little.

Comparing your current abilities with your own previous abilities may reveal much more.

Healthy aging is partly about preserving capacity

Aging cannot be stopped.

Muscle mass tends to decline. Mitochondrial function changes. Recovery may become slower, and physiological reserve can decrease.

But the rate at which these changes occur is not identical from one person to another.

The webinar repeatedly returned to the role of continued physical activity, nutrition, muscle use, and mitochondrial function in maintaining physical capacity over time.

That shifts the question away from:

How do we prevent aging?

and toward something more useful:

How much function can we preserve as we age?

Strength matters because it allows movement.

Movement matters because it helps maintain muscle and bone.

Mitochondrial function matters because those tissues need energy to perform their work.

And maintaining physical capacity can help people continue doing the activities that support independence later in life.

Continue the Discussion in Mito-Hackers

This Briefing is based on a recent Mito-Hackers webinar with Dr. Francisco Villarreal, Co-Founder and Chief Medical Officer of FMG Health Sciences.

Mito-Hackers members can watch the full presentation and Q&A, where Dr. Villarreal discusses mitochondrial aging, frailty, sarcopenia, muscle function, exercise, and research involving (-)-epicatechin in greater detail.

Already a member? Sign in to Mito-Hackers to watch the complete webinar.

Interested in joining? Apply for access to participate in future webinars, scientific discussions, and member-only content.

This Briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

Has the incision healed? Has the swelling gone down? Can the patient move normally again?

In our latest Mito-Hackers webinar, Dr. Francisco Villarreal looked at recovery from a different perspective:

What is happening inside the body as it responds to the stress of surgery?

His presentation focused on several connected processes, including blood flow, inflammation, tissue repair, muscle function and mitochondrial energy.

Together, they offer a broader way to think about recovery.

Surgery is a controlled injury

Dr. Villarreal described surgery as a form of controlled tissue injury.

Even when a procedure is medically necessary and successful, the body still has to respond to cutting, bleeding, tissue disruption and inflammation.

Recovery therefore involves much more than closing an incision.

The body must control bleeding, restore adequate circulation, activate immune responses, produce new tissue and eventually remodel the repaired area.

Those processes unfold over different periods of time.

Bleeding must be controlled almost immediately. Inflammation develops over the following hours and days. Tissue repair and remodeling can continue for weeks or months.

The goal is not to prevent these responses.

It is to keep them appropriately regulated.

What determines whether recovery goes well?

Dr. Villarreal highlighted several factors that can affect surgical recovery.

Adequate blood flow is essential because recovering tissue needs oxygen and nutrients.

Nutrition matters, particularly adequate protein.

Patients also benefit from controlling underlying conditions such as diabetes, avoiding smoking, sleeping adequately and beginning to move again as soon as medically appropriate.

Inflammation is another part of the equation.

Some inflammation is necessary for healing. But Dr. Villarreal explained that excessive or prolonged inflammation may interfere with tissue repair and contribute to a more difficult recovery.

This becomes especially relevant in older patients and in people who already have conditions associated with impaired circulation, metabolic dysfunction or chronic inflammation.

Why mitochondria matter during recovery

All of these processes require energy.

Mitochondria produce ATP, the form of cellular energy used throughout the body.

During recovery, ATP is required for processes involved in inflammation, tissue repair, collagen production, scar formation and remodeling.

But mitochondria do more than produce energy.

Dr. Villarreal also discussed their relationship with oxidative stress.

Healthy mitochondria normally generate relatively low levels of reactive oxygen species. Damaged or dysfunctional mitochondria, however, may produce less ATP while contributing to higher oxidative stress.

That matters after surgery because tissue injury already activates inflammatory pathways.

Dr. Villarreal therefore described recovery as a balance between energy production, oxidative stress and inflammation.

When those systems remain well regulated, the environment is more favorable for healing and restoration of function.

Recovery also depends on blood flow

Another recurring theme was circulation.

Healing tissue requires a reliable supply of blood, oxygen and nutrients.

New blood vessels may also need to form as damaged tissue is repaired and remodeled.

Dr. Villarreal connected this to endothelial function, the biology of the cells lining blood vessels.

This means mitochondrial health and vascular health are not completely separate questions.

A recovering tissue needs enough energy to perform repair, but it also needs the circulation required to deliver the materials that make repair possible.

Where does (−)-epicatechin fit?

The final part of the presentation examined research involving (−)-epicatechin.

Dr. Villarreal reviewed studies conducted by his research group and collaborators involving several models of injury and impaired function.

These included animal studies involving cardiac injury, kidney injury and spinal cord injury, along with research examining mitochondrial function, muscle and aging.

He described this body of work as providing direct and indirect evidence relevant to some of the biological processes involved in surgical recovery.

That distinction is important.

The webinar was not presenting a clinical trial showing that (−)-epicatechin improves surgical outcomes in patients.

Instead, Dr. Villarreal's argument was based on biological systems that may matter during recovery, including mitochondrial function, cellular energy, vascular function and muscle preservation.

What happens to muscle during inactivity?

The Q&A moved into another problem familiar to many surgical patients: muscle loss during periods of inactivity.

A participant asked whether (−)-epicatechin might be relevant to the muscle deterioration that can occur during prolonged bed rest.

Dr. Villarreal discussed an animal study involving spinal cord injury in which animals receiving (−)-epicatechin showed greater preservation of muscle mass than animals receiving placebo.

He compared this with a familiar example.

When a leg is immobilized in a cast for an extended period, the muscles in that leg become visibly smaller because they are not being used.

That is one reason mobility came up repeatedly during the presentation.

When medically possible, getting patients moving again is an important part of recovery.

Preparing before surgery

The discussion eventually turned to what can be done before a planned operation.

Dr. Villarreal emphasized preparation.

That can include good nutrition, control of existing medical conditions, avoiding smoking, adequate sleep and physical activity when possible.

Exercise presents an interesting challenge.

Someone preparing for a hip or knee replacement may benefit from being physically stronger before surgery, but the condition requiring surgery may also make exercise difficult.

That makes preparation highly individual.

The larger idea was simple:

The condition in which the body enters surgery may influence how well it handles the demands that follow.

Recovery is a whole-body process

Perhaps the clearest message from the webinar was that surgery should not be viewed only through the part of the body being operated on.

A hip replacement involves more than the hip.

A prostate procedure involves more than the prostate.

Recovery requires coordination among circulation, immune responses, inflammation, muscle, metabolism and cellular energy production.

Mitochondria sit within that larger network.

They are not the only factor determining recovery, but they help supply the energy required for many of the processes that allow tissue to repair and function to return.

When Dr. Villarreal was asked what he most wanted viewers to remember, his answer was straightforward:

Be prepared.

When surgery is planned in advance, the weeks and months before the procedure offer an opportunity to improve the condition in which the body enters that challenge.

And from the mitochondrial perspective, recovery begins before the first incision is ever made.

Watch the Webinar

Mito-Hackers members can watch the complete webinar in two parts:

Part 1: Main Presentation
Dr. Francisco Villarreal discusses the biology of surgical recovery, mitochondrial function, oxidative stress, inflammation and research involving (−)-epicatechin.

Part 2: Questions and Answers
The discussion continues with questions about pre-surgical preparation, muscle loss during inactivity, mitochondrial function and recovery.

Visit the Webinars & Events space to watch the recordings.

Continue the Conversation

Which part of surgical recovery deserves more attention: mitochondrial energy, inflammation, circulation, muscle preservation or preparing the body before surgery?

Interested in joining Mito-Hackers? Learn more about the community and apply for access to participate in future webinars and scientific discussions.

This briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

In our recent Mito-Hackers webinar, Zita Desmet asked a different question:

What is actually happening within the skin as it gets older?

Her presentation centered on three connected processes: cellular turnover, communication between cells, and mitochondrial energy.

Together, they offer a different way to think about skin longevity. Instead of focusing only on how old skin looks, the discussion focused on how well skin continues to protect, renew and maintain itself over time.

Skin is constantly balancing defense and renewal

Zita began with two fundamental jobs of the skin.

The first is defense. Skin forms the interface between the body and the outside environment and must continually respond to ultraviolet light, pollution, oxidative stress and other external influences.

The second is renewal. Older and damaged cells must be replaced while the skin maintains an effective protective barrier.

Zita described these processes as a balance. When the skin is continually dealing with outside stressors, more of its resources may be directed toward defense, potentially leaving less capacity for effective renewal.

That tension between protecting the tissue and renewing it became one of the central themes of the webinar.

What happens to cellular turnover as skin ages?

Skin renewal is a continuing biological process.

New keratinocytes are produced near the base of the epidermis. As they move toward the surface, they change in form and function, contribute to the protective barrier and are eventually shed.

Zita described an approximate 28-day turnover cycle in younger skin, with the process potentially extending to 45 to 60 days in older skin.

But faster is not necessarily better.

During the Q&A, Mani asked whether cellular turnover could become too fast. Zita explained that both extremes can be undesirable. Turnover that becomes too slow may interfere with effective renewal, while excessively rapid turnover may not allow cells enough time to mature properly and form an effective barrier.

The goal, in other words, is not maximum turnover.

It is appropriate, well-regulated turnover.

Skin aging goes deeper than the surface

The presentation also looked at the different layers of the skin.

The epidermis forms the outer layer and plays an important role in barrier function and cellular renewal.

Beneath it lies the dermis, where much of the skin's structural support is found.

Zita discussed several components of this environment, including collagen, elastin, hyaluronic acid and fibroblasts.

Collagen receives enormous attention in conversations about skin aging, but the webinar made an important point: collagen does not exist by itself.

It is part of living tissue.

Fibroblasts produce and maintain components of the extracellular matrix. Blood vessels supply the tissue. Cells communicate with one another. Inflammatory processes, oxidative stress and changes elsewhere in the body can influence the environment in which those cells operate.

Looking only at collagen therefore tells us only part of the story.

From collagen to cellular communication

This broader view led into another theme from Zita's presentation: communication between cells.

Healthy tissue depends on cells being able to respond to their surroundings and to signals from other cells.

During aging, Zita discussed several processes that may interfere with that environment, including glycation, oxidative stress, inflammation and cellular senescence.

She also introduced the concept of “inflammaging” and discussed how senescent cells can remain within tissue while influencing the cells around them.

Rather than looking at each of these processes in isolation, Zita's presentation placed them within the larger question of whether aging skin can continue to communicate, repair itself and respond appropriately to stress.

That leads to another question:

Where does the energy required to do all of this come from?

Mitochondrial energy and skin longevity

Mitochondria are usually discussed in relation to metabolism and energy production, but Zita argued that they also deserve more attention in conversations about skin aging.

Her reasoning was straightforward.

Cells require energy to function.

Renewal requires energy. Repair requires energy. Maintaining the skin barrier requires energy. Responding to environmental stress and communicating with surrounding cells also require functioning cellular machinery.

Zita therefore placed mitochondrial energy alongside cellular turnover and communication as one of the foundations of her skin-longevity framework.

The presentation discussed several approaches intended to influence mitochondrial function in skin, including photobiomodulation, supplementation and targeted topical delivery. High-purity (−)-epicatechin was also discussed within this context.

But the larger idea went beyond any one intervention.

Rather than asking only what can be applied to the surface of the skin, Zita encouraged the audience to think about the condition and capacity of the cells underneath it.

Building metabolic resilience

Zita used the term metabolic resilience to describe the ability of skin cells to continue functioning despite the stresses they encounter.

She grouped some of these challenges into broad categories that included sugar-related stress, oxidative stress and external environmental stress.

Skin is exposed to these pressures repeatedly throughout life.

The question therefore becomes less about eliminating every source of stress and more about whether the tissue can continue to defend itself, recover and renew.

This changes the way we think about skin longevity.

A wrinkle is something we can see.

The biological processes that eventually contribute to it may have been developing for years beneath the surface.

The Q&A went beyond the presentation

The audience discussion took several of these ideas further.

Dr. Francisco Villarreal expanded on the relationship between collagen, fibroblasts, inflammation, oxidative stress and the tissue environment, including the importance of blood flow and microcirculation.

The group also discussed what happens when common skincare practices become too aggressive and potentially interfere with the skin barrier.

A question about microneedling led to a broader conversation about controlled stress, tissue repair and whether the condition of the underlying cells affects the response to an intervention.

And near the end of the Q&A, Zita was asked a particularly practical question:

If you wanted your skin to function as well as possible 20 years from now, what three things would you prioritize today?

Her answer brought the conversation back to many of the themes that had appeared throughout the webinar.

We will leave that answer for the recording.

From “anti-aging” to skin longevity

Perhaps the clearest summary of Zita's framework came at the end of her presentation:

Turnover + communication + mitochondrial energy = cell longevity.

That equation captures the difference between the traditional language of “anti-aging” and the idea of skin longevity.

Anti-aging often begins with something visible and asks how we can change it.

Skin longevity asks a more basic set of questions.

How effectively are skin cells renewing?

Are they communicating properly?

Can the tissue respond to stress and repair itself?

Do those cells have the energy needed to continue doing their jobs?

Seen this way, skin aging is not simply about how many wrinkles appear on the surface.

It is about how well living tissue continues to function as it gets older.

Watch the Webinar

Mito-Hackers members can watch the complete conversation in two parts:

Part 1: Main Presentation
Zita Desmet presents her framework for skin longevity, cellular turnover, communication and mitochondrial energy.

Part 2: Questions and Answers
The discussion continues with questions about collagen, circulation, skincare practices, microneedling, metabolic health and what we can do today to support skin over the long term.

Watch the Webinar

Mito-Hackers members can watch the complete webinar in two parts:

Part 1: Main Presentation

Part 2: Questions and Answers

Visit the Webinars & Events space to watch the recordings.

Continue the Conversation

Which part of the presentation deserves the most attention: mitochondrial function in skin, oxidative stress, vascular support, the measurement methods, or the early topical epicatechin findings?

Interested in joining Mito-Hackers? Learn more about the community and apply for access to participate in future webinars and scientific discussions.

This briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

His presentation examined a practical question that grew out of earlier epicatechin research: Could a compound studied in relation to mitochondrial and vascular biology also influence measurable features of aging skin when applied topically?

Skin Aging Is More Than a Surface Problem

Dr. Ceballos described skin aging as the combined result of intrinsic and extrinsic factors. Intrinsic aging includes time-dependent changes in DNA stability, immune regulation, metabolism, and cellular repair. Extrinsic factors include ultraviolet exposure, smoking, radiation, and excessive alcohol use.

These influences can increase oxidative stress and place additional strain on mitochondria and other cellular systems. Over time, reduced repair capacity and continued molecular damage may contribute to visible changes such as wrinkles, uneven pigmentation, and loss of smoothness.

The central point was not that mitochondria are the only drivers of skin aging. It was that the skin is living, energy-dependent tissue, so its appearance cannot be separated completely from cellular function.

Why Mitochondria Matter in Skin

Mitochondria provide ATP, the usable energy cells need for maintenance, repair, signaling, and normal tissue function. They also participate in oxidative signaling and interact with vascular and endothelial systems that help supply tissues with oxygen and nutrients.

Dr. Ceballos reviewed earlier work in muscle and vascular biology that led his team to ask whether some of the same epicatechin-related pathways might also be relevant in skin. That earlier research provided the rationale for the skin work, but it did not by itself prove that a topical formulation would change skin appearance. The topical question had to be tested directly.

Why Study (−)-Epicatechin Topically?

(−)-Epicatechin is a flavanol studied in connection with receptor-mediated cellular signaling, mitochondrial biology, vascular function, and oxidative balance. Dr. Ceballos explained that the team developed a topical formulation so the compound could be studied directly at the skin rather than assuming that findings from oral or systemic research would automatically translate to topical use.

This work contributed to the development of Mitozz RS, a topical cosmetic serum formulated with 98% pure (−)-epicatechin.

How the Skin Study Was Conducted

The presentation described exploratory work involving both the hands and face. The epicatechin-containing serum was compared with a matching formulation without epicatechin, and changes were followed over periods of approximately four to eight weeks.

For the hand measurements, dental casts were used to help reproduce positioning and reduce inconsistencies between images. The researchers also used three-dimensional surface profilometry to measure features such as wrinkle height, valley depth, and the total surface profile.

For the facial examples, a placebo period was followed by use of the epicatechin formulation. The combination of standardized imaging and quantitative surface measurements was intended to evaluate skin texture more objectively than photographs alone.

What the Researchers Reported

In the examples presented, the placebo period produced little visible or measured change. After the epicatechin formulation was introduced, the researchers reported reductions in measured wrinkle height and valley depth, producing a smoother surface profile.

“Wrinkles do not disappear; they decrease in height.”

That distinction matters. The presentation did not show that skin aging had been reversed or that wrinkles had been erased. It showed that specific surface measurements became less pronounced in the examples analyzed.

These findings are best understood as exploratory evidence that supports further study. They should not be treated as the equivalent of a large, independently replicated clinical trial.

What the Q&A Added

The discussion after the presentation addressed several practical and scientific questions:

• Time course: The examples presented showed changes over roughly one to two months, with consistent use described as important.

• Daily routine: Dr. Ceballos discussed allowing the serum to dry before applying other products and continuing to use sun protection during the day.

• Formulation: Epicatechin was the active variable under discussion, while the serum base included other ingredients needed for stability and cosmetic use.

• Local versus systemic use: A topical product is intended to act at the skin and should not be assumed to produce the same systemic exposure as an oral formulation.

• Concentration: More is not necessarily better. Dr. Ceballos described receptor-mediated effects as operating within a response window rather than increasing indefinitely with dose.

• Future questions: Pigmentation, inflammatory skin conditions, and other possible applications remain areas for further research rather than established cosmetic claims.

Cosmetic Use Versus Future Medical Research

Near the end of the presentation, Dr. Ceballos briefly discussed exploratory observations that could justify future medical research involving topical epicatechin. He also stated that controlled clinical trials would be needed before drawing conclusions about therapeutic uses.

Those possibilities remain research questions. They should not be presented as current uses of Mitozz RS, which is a topical cosmetic serum intended to hydrate and condition the skin while helping improve the appearance of fine lines and supporting smoother, more even-looking skin.

The Main Takeaway

The presentation connected visible skin aging with the energy, signaling, vascular, and repair systems operating beneath the surface. Its strongest contribution was not the idea of another “anti-aging ingredient,” but a testable biological question supported by measurable changes in skin-surface geometry.

The findings suggest that topical (−)-epicatechin deserves further study in relation to the appearance of wrinkles and skin texture. They do not show that it reverses aging, erases wrinkles, or treats a medical skin condition.

Watch the Webinar

Mito-Hackers members can watch the complete webinar in two parts:

Part 1: Main Presentation
Epicatechin and Skin Health: From Mechanisms to Beauty, a New Form to Reduce Wrinkles

Part 2: Questions and Answers

Visit the Webinars & Events space to watch the recordings.

Continue the Conversation

Which part of the presentation deserves the most attention: mitochondrial function in skin, oxidative stress, vascular support, the measurement methods, or the early topical epicatechin findings?

Interested in joining Mito-Hackers? Learn more about the community and apply for access to participate in future webinars and scientific discussions.

This briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

His presentation examined an emerging question in endometriosis research: Could mitochondrial dysfunction and altered cellular energy help explain parts of the disease that cannot be understood through hormones alone?

Endometriosis Is More Than a Hormonal Condition

Endometriosis has traditionally been viewed primarily as a hormone-related disease. Dr. Upadhyaya did not argue that hormones are unimportant. Instead, he described endometriosis as a multifactorial condition involving several interacting biological processes, including:

• Hormonal signaling

• Genetics

• Immune dysfunction

• Inflammation

• Oxidative stress

• Mitochondrial dysfunction

His central point was that mitochondria do not replace hormones in the endometriosis story. They may help explain how cells respond to hormonal and inflammatory signals.

Looking at both systems together may offer a more complete way to think about why endometriosis develops, persists, and affects women differently.

Why Mitochondria Matter

Mitochondria are usually introduced as the structures that produce cellular energy in the form of ATP. Dr. Ram described their role more broadly, discussing their involvement in:

• Cellular energy production

• Cell survival and repair

• Oxidative stress

• Inflammatory signaling

• Immune function

• Hormonal responses

He also discussed the balance between mitochondrial biogenesis, the production of new mitochondria, and mitophagy, the removal of damaged mitochondria.

When damaged mitochondria accumulate or cellular energy production falls, cells may have greater difficulty maintaining normal repair, communication, and immune regulation.

From Oxidative Stress to Inflammation and Pain

During the presentation, Dr. Ram outlined a possible cycle connecting oxidative stress, mitochondrial damage, inflammation, and pain.

In this model, oxidative stress can damage mitochondrial structures and interfere with energy production. Reduced cellular energy may then impair repair processes, while continued immune activation changes the environment around the affected tissue.

As inflammation persists, tissue damage, new blood-vessel formation, scar tissue, and nerve sensitization may contribute to continuing or worsening pain.

Dr. Ram stressed that pain should not be treated as an isolated symptom:

“Pain is not simply a symptom. Pain is a whole biology.”

This may help explain why the pain associated with endometriosis can be persistent and why reducing pain alone does not necessarily address all the biological processes involved.

Endometriosis, Cellular Energy, and Fertility

Dr. Ram also used reproductive biology to illustrate why cellular energy matters to women’s health.

He discussed the high energy demands associated with egg development, fertilization, pregnancy, and placental function. He described hormones and mitochondria as interconnected systems: hormones influence mitochondrial activity, while mitochondria provide the energy cells need to respond to hormonal signals.

This relationship may be especially relevant when considering endometriosis, infertility, reproductive aging, and the physical and emotional burden experienced by women seeking fertility treatment.

Common Myths About Endometriosis

Near the end of the presentation, Dr. Ram addressed several common misconceptions.

Myth 1: Endometriosis is just painful periods

He described it as a chronic inflammatory condition that may also be associated with infertility, fatigue, pelvic pain, pain during intercourse, and symptoms extending beyond menstruation.

Myth 2: Endometriosis is exclusively hormonal

Hormones are involved, but Dr. Ram also discussed the possible contributions of genetics, immune dysfunction, inflammation, oxidative stress, and mitochondrial dysfunction.

Myth 3: Surgery cures endometriosis

Surgery may remove lesions and relieve symptoms, but Dr. Ram noted that lesions and symptoms can recur after surgery.

Myth 4: More pain always means more extensive disease

The severity of pain does not necessarily correspond to the visible number or extent of endometriotic lesions.

Myth 5: Nothing new is happening in endometriosis research

Dr. Ram pointed to emerging work involving mitochondrial biology, immunology, immunotherapy, multiomics, and precision medicine.

Looking Toward a Broader Understanding

The presentation did not suggest that mitochondrial dysfunction is the sole cause of endometriosis. Instead, Dr. Ram presented it as one possible contributor within a much broader biological system.

Understanding how cellular energy interacts with hormones, inflammation, oxidative stress, immune function, and pain may help researchers ask new questions about the disease.

Dr. Ram described hormones and mitochondria as a kind of “twin engine,” with each system supporting the other. Hormones help regulate and protect mitochondrial function, while mitochondria provide cellular energy and support the production of steroid hormones. The first step in steroid hormone synthesis begins inside the mitochondria, making their relationship reciprocal rather than one-directional.

Hormones tell cells what to do, but mitochondria give those cells the energy to do it.

This energy relationship is only part of the connection. Mitochondria also support steroid hormone production, while hormones help regulate mitochondrial health and activity.

Considering both systems together may help provide a fuller understanding of endometriosis and the health challenges women experience.

Watch the Webinar

Mito-Hackers members can watch the complete webinar in two parts:

Part 1: Main Presentation
Endometriosis: An Energy Crisis Inside Women’s Cells

Part 2: Questions and Answers

Visit the Webinars & Events space to watch the recordings.

Continue the Conversation

Which part of this emerging model deserves the most attention: mitochondrial function, oxidative stress, immune signaling, pain biology, or the interaction between hormones and cellular energy?

Interested in joining Mito-Hackers? Learn more about the community and apply for access to participate in future webinars and scientific discussions.

This briefing is intended for educational and scientific discussion only. It should not be interpreted as medical advice, diagnosis, or treatment guidance.

The session examined how the evidence for (−)-epicatechin compares with that available for other compounds commonly associated with mitochondrial health.

Rather than relying on a single experiment or outcome, Dr. Villarreal reviewed the evidence across several levels, including pharmacology, molecular mechanisms, preclinical research, human studies, large population studies, and longevity research. A central theme was that compounds should be evaluated by the breadth, consistency, and quality of the research behind them, not simply by their popularity or marketing claims.

The Q&A covered supplement purity and dosing, how (−)-epicatechin is absorbed and metabolized, safety considerations, and its relationship to mitochondrial function and oxidative stress.

For those interested in taking a deeper look, our Supplement Comparison page examines how (−)-epicatechin compares with other commonly discussed compounds across evidence, mechanisms, safety, and practical use.

The video recording will be added to the Webinars & Events space soon.

For now, we’d love to hear from you:

Which type of evidence matters most to you when evaluating a supplement: biological mechanisms, human trials, long-term population data, or something else?